Perfil
El Dr. Ken Takeshita, MD, es Director Global de Investigación y Desarrollo en Daiichi Sankyo Co. El Dr. Takeshita trabajó anteriormente como Vicepresidente Senior y Jefe Global de Desarrollo Clínico en Kite Pharma, Inc.
Cargos activos de Ken Takeshita
| Empresas | Cargo | Inicio |
|---|---|---|
| DAIICHI SANKYO CO., LTD. | Chief Tech/Sci/R&D Officer | 01/04/2021 |
Antiguos cargos conocidos de Ken Takeshita.
| Empresas | Cargo | Fin |
|---|---|---|
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | 09/02/2021 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| DAIICHI SANKYO CO., LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Ken Takeshita
